Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving (177)Lu-PSMA-617 Radioligand Therapy

Rationale: PSMA-PET-CT enables measuring molecular expression of prostate-specific membrane antigen (PSMA) in vivo, which is the target molecule of (177)Lu-PSMA-617 (Lu-PSMA) therapy. However, the correlation of PSMA expression and overall survival (OS) in patients treated with Lu-PSMA therapy is cu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Theranostics
Päätekijät: Seifert, Robert, Seitzer, Konstantin, Herrmann, Ken, Kessel, Katharina, Schäfers, Michael, Kleesiek, Jens, Weckesser, Matthias, Boegemann, Martin, Rahbar, Kambiz
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2020
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7359095/
https://ncbi.nlm.nih.gov/pubmed/32685021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.47251
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia